RECRUITING

Congenital Uterine Anomalies: Identifying Cancer Associations and Genetic and Environmental Factors to Improve Clinical Care

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this research study is to learn more about the health outcomes associated with congenital uterine anomalies (CUAs), and the possible environmental and genetic causes of the condition. The researchers plan to investigate whether any cancer associations (with breast, renal, ovarian, vaginal and uterine cancers) exist in females with CUAs. The investigator will also investigate any environmental and genetic factors that may be responsible for causing CUAs.

Official Title

Congenital Uterine Anomalies: Identifying Cancer Associations and Genetic and Environmental Factors to Improve Clinical Care

Quick Facts

Study Start:2021-07-14
Study Completion:2026-03
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04661072

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:13 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * females
  2. * age: 13 or older
  3. * encounters limited to: Yale New Haven Hospital, Bridgeport Hospital, Greenwich Hospital and Lawrence+ Memorial Hospital.
  4. * diagnosis of any variation of CUA
  1. * who will decline to participate in a study upon contact
  2. * non-English speaking except Spanish speaking
  3. * unable to participate in consent or assent process due to mental disability

Contacts and Locations

Study Contact

Alla Vash-Margita, MD
CONTACT
203-785-4010
alla.vash-margita@yale.edu
Miranda Margetts, PhD
CONTACT
miranda.margetts@yale.edu

Principal Investigator

Alla Vash-Margita, MD
PRINCIPAL_INVESTIGATOR
Yale University
Emanuele Pelosi, MD
PRINCIPAL_INVESTIGATOR
Yale University

Study Locations (Sites)

Yale University
New Haven, Connecticut, 06511
United States

Collaborators and Investigators

Sponsor: Yale University

  • Alla Vash-Margita, MD, PRINCIPAL_INVESTIGATOR, Yale University
  • Emanuele Pelosi, MD, PRINCIPAL_INVESTIGATOR, Yale University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-07-14
Study Completion Date2026-03

Study Record Updates

Study Start Date2021-07-14
Study Completion Date2026-03

Terms related to this study

Keywords Provided by Researchers

  • Cancer associations
  • Environmental factors

Additional Relevant MeSH Terms

  • Congenital Uterine Anomaly